Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-4,747
Closed -$284K – 238
2018
Q1
$284K Sell
4,747
-2,038
-30% -$136K 0.05% 191
2017
Q4
$534K Sell
6,785
-435
-6% -$35.1K 0.09% 155
2017
Q3
$606K Sell
7,220
-229
-3% -$16.2K 0.1% 137
2017
Q2
$487K Sell
7,449
-29
-0.4% -$1.97K 0.09% 145
2017
Q1
$543K Buy
7,478
+1,542
+26% +$101K 0.1% 136
2016
Q4
$348K Buy
+5,936
New +$313K 0.07% 150

Other funds holding ADNT

Foster & Motley's ADNT Position: Q2 2018 in Review

Foster & Motley sold out of Adient (ADNT) in Q2 2018, closing a stake of 4,747 shares — an estimated $284K sold.

Foster & Motley first reported a position in ADNT in Q4 2016 and held it in 6 quarters. The position peaked at $606K in Q3 2017. 377 funds tracked by Wall St. Rank hold ADNT as of Q2 2018.

  • Foster & Motley reported no remaining Adient position as of Q2 2018 after selling out during the quarter.
  • Foster & Motley sold 4,747 Adient shares in Q2 2018, an estimated $284K.
  • Foster & Motley first reported a position in Adient in Q4 2016 and held it in 6 quarters.
  • Foster & Motley's Adient position peaked at $606K in Q3 2017.
  • 377 funds tracked by Wall St. Rank held Adient as of Q2 2018.

Based on Foster & Motley's 13F filing for Q2 2018, filed 24 Jul 2018.